They can be used in patients with an estimated glomerular filtration rate over 15 mL/min/1.73 m 2
Because GLP-1 medications deliver much higher levels of the hormone than the body naturally produces in the joints, researchers believe these drugs could potentially affect inflammation in those tissues
Genetic differences, beta-cell function, and baseline insulin resistance can all influence treatment response
The findings of this work clearly indicate that ALC has a neurotherapeutic impact in a 6-OHDA-mediated model of PD by inhibiting apoptosis, neuroinflammation, astrogliosis, and OS, and that it might be considered as a potential supplementary treatment option for PD management (Afshin-Majd et al., 2017)
Semaglutide significantly reduces appetite, and some patients inadvertently under-eat relative to their activity level, especially as doses increase
Deciphering the gut microbiome: the revolution of artificial intelligence in microbiota analysis and intervention